PremiumCompany AnnouncementsSareum Holdings to Announce Half-Year Results and Host Investor Presentation Sareum Holdings Secures £1.07 Million in Institutional Fundraise Sareum Holdings Acquires Licence for SRA737, Strengthening Oncology Portfolio PremiumCompany AnnouncementsSareum Holdings Adjusts Share Capital with New Options and Shares Sareum Holdings Announces AGM and Progress in Drug Development Sareum Holdings Advances in Autoimmune and Cancer Drug Development PremiumCompany AnnouncementsSareum Holdings Announces Executive Reshuffle Sareum Holdings Reports Promising Phase 1 Results Sareum Holdings Appoints New Sole Broker